Avecho Biotechnology Limited (OEZ) — Cash Flow-to-Debt Ratio
Avecho Biotechnology Limited (OEZ) has a Cash Flow-to-Debt Ratio of -0.88x as of December 2022, meaning its operating cash flow of €-808.80K could theoretically repay -1% of its total liabilities (€920.66K) in one year. See OEZ financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Avecho Biotechnology Limited Cash Flow-to-Debt Ratio (2013–2022)
Historical debt coverage capacity for Avecho Biotechnology Limited across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Avecho Biotechnology Limited.
Annual Cash Flow-to-Debt Ratio for Avecho Biotechnology Limited (2013–2022)
Year-by-year debt coverage analysis for Avecho Biotechnology Limited. Check Avecho Biotechnology Limited earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.81x | €-1.67 Million | €920.66K | ▲ +58.6% |
| 2021 | -4.37x | €-3.10 Million | €709.36K | ▼ -114.8% |
| 2020 | -2.03x | €-1.42 Million | €700.17K | ▼ -196.0% |
| 2019 | 2.12x | €1.18 Million | €556.12K | ▲ +187.3% |
| 2018 | -2.43x | €-2.19 Million | €902.04K | ▲ +30.7% |
| 2017 | -3.50x | €-6.42 Million | €1.84 Million | ▲ +6.9% |
| 2016 | -3.76x | €-6.41 Million | €1.71 Million | ▲ +21.6% |
| 2015 | -4.79x | €-8.71 Million | €1.82 Million | ▼ -33.2% |
| 2014 | -3.60x | €-6.74 Million | €1.87 Million | ▲ +8.3% |
| 2013 | -3.92x | €-8.58 Million | €2.19 Million | — |